| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.661 | 38.840 | 38.151 | 39.874 | 46.599 | 27.848 | 31.853 | 37.863 | 37.924 | 50.318 |
| Total Income - EUR | 29.747 | 38.856 | 38.227 | 40.055 | 46.787 | 32.751 | 36.840 | 40.719 | 37.962 | 50.321 |
| Total Expenses - EUR | 30.487 | 38.584 | 41.849 | 42.757 | 44.246 | 30.921 | 32.674 | 38.745 | 45.317 | 50.874 |
| Gross Profit/Loss - EUR | -740 | 272 | -3.622 | -2.702 | 2.541 | 1.830 | 4.166 | 1.974 | -7.355 | -554 |
| Net Profit/Loss - EUR | -1.631 | -117 | -4.009 | -3.103 | 2.073 | 1.615 | 3.993 | 1.656 | -7.709 | -2.063 |
| Employees | 4 | 4 | 4 | 4 | 3 | 3 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Perscris 86 Com S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.113 | 3.562 |
| Current Assets | 2.253 | 1.553 | 1.451 | 1.521 | 1.489 | 863 | 2.639 | 2.441 | 2.646 | 2.631 |
| Inventories | 1.354 | 786 | 920 | 1.408 | 1.048 | 481 | 938 | 1.361 | 1.238 | 1.152 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 | 52 |
| Cash | 899 | 767 | 531 | 113 | 441 | 382 | 1.701 | 1.081 | 1.380 | 1.427 |
| Shareholders Funds | -1.587 | -1.687 | -5.668 | -8.666 | -6.425 | -4.688 | -591 | 1.063 | -6.650 | -8.676 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.881 | 3.240 | 7.119 | 10.187 | 7.914 | 5.552 | 3.110 | 1.378 | 13.408 | 14.869 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 120 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Perscris 86 Com S.r.l.